Third Harmonic Bio (THRD) Earnings Date & Reports

Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

THRD is expected to report earnings to fall 8.62% to -26 cents per share on May 08

Third Harmonic Bio THRD Stock Earnings Reports

Q1'25

Est.

$-0.26

Q4'24

Beat

by $0.06

Q3'24

Missed

by $0.03

Q2'24

Missed

by $0.01

Q1'24

Beat

by $0.11

The last earnings report on March 27 showed earnings per share of -28 cents, beating the estimate of -35 cents. With 375.15K shares outstanding, the current market capitalization sits at 161.02M.

View a ticker or compare two or three

Compare

THRD